Evidence map›Paper›PMID 30028339›Full record

ArticleNeural regeneration research2018

Degree of dopaminergic degeneration measured by

Ling Lin, Jing Ye, Han Zhang, Zhong-Fu Han, Zhi-Hong Zheng

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neural regeneration research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Preclinical evaluation of [EJNMMI research · 2024
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ling LinFujian Provincial Key Laboratory of Neuroglia and Disease, Fujian Medical University; Department of Biochemistry and Molecular Biology, Fujian Medical University, Fuzhou, Fujian Province, China.
Jing YeDepartment of Biochemistry and Molecular Biology, Fujian Medical University, Fuzhou, Fujian Province, China.
Han ZhangDepartment of Biochemistry and Molecular Biology, Fujian Medical University, Fuzhou, Fujian Province, China.
Zhong-Fu HanDepartment of Biochemistry and Molecular Biology, Fujian Medical University, Fuzhou, Fujian Province, China.
Zhi-Hong ZhengFujian Provincial Key Laboratory of Neuroglia and Disease, Fujian Medical University; Department of Biochemistry and Molecular Biology, Fujian Medical University, Fuzhou, Fujian Province, China.
Fujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To prevent and treat Parkinson's disease in its early stages, it is essential to be able to detect the degree of early dopaminergic neuron degeneration. Dopamine transporters (DAT) in the striatum regulate synaptic dopamine levels, and striatal

Indexed as

6-hydroxydopamine99mTc-TRO–DAT-1apomorphinedopaminergic degenerationdopamine transporternerve regenerationneural regenerationneurodegenerationParkinson's diseasesingle-photon emission computed tomographystriatumsubstantia nigratyrosine hydroxylase

Identifiers

PMID30028339
PMCPMC6065227
OpenAlexW2884709581

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.